Industry News

GSK sells Australian drugs to Aspen for $270 mln

August 15, 2012 Comments Off on GSK sells Australian drugs to Aspen for $270 mln

August 15, 2012, 9:40 am

JOHANNESBURG/LONDON (Reuters) – GlaxoSmithKline advanced its clear-out of non-core drugs on Wednesday with a deal to sell 25 older brands marketed in Australia to South Africa’s Aspen Pharmacare for 172 million pounds.
Andrew Witty, chief executive of Britain’s bigge…

Powered by WPeMatico

Comments are closed.